Tender detail

Conclusion of a non-exclusive pharmaceutical discount agreement for onabotulinumtoxin A

Summary

DAK-Gesundheit is procuring pharmaceutical discount agreements for the active substance botulinum toxin type A, limited to onabotulinumtoxin (ATC M03AX21). The agreements are planned for the period from 1 December 2026 to 30 November 2028 and are to be concluded with as many interested pharmaceutical companies as possible. They will end automatically when a new exclusive agreement takes effect.

Reference number
d34efb02-4943-4567-929e-0ea9d7e08b55
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.